Bitte beachten Sie: Diese Stellenanzeige ist nicht mehr aktiv.
Entdecken Sie hier weitere Stellenanzeigen auf academics, dem führenden Stellenmarkt für Wissenschaft und Forschung. Um regelmäßig per E-Mail über passende Stellen informiert zu werden, können Sie sich jederzeit kostenlos registrieren.
Group leader (f/m) induced pluripotent stem cells and brain malignancies
Veröffentlicht am(vor 946 Tagen)
Deutsches Krebsforschungszentrum / German Cancer Research Center (DKFZ)Heidelberg
The German Cancer Research Center is committed to increase the percentage of female scientists and encourages female applicants to apply. Among candidates of equal aptitude and qualifications, a person with disabilities will be given preference.
To apply for a position please use our online application portal (www.dkfz.de).
We ask for your understanding that we cannot return application documents that are sent to us by post (Deutsches Krebsforschungszentrum, Personal- und Sozialwesen, Im Neuenheimer Feld 280, 69120 Heidelberg) and that we do not accept applications submitted via email. We apologize for any inconvenience this may cause.
The German Cancer Research Center is the largest biomedical research institution in
Germany. With approximately 2,900 employees, we operate an extensive scientific program
in the field of cancer research.
A unique opportunity to establish your independent
Group leader position
induced pluripotent stem cells and brain malignancies
The German Cancer Research Center (DKFZ) and the Central Institute of Mental Health (CIMH) together with the Hans-Werner Hector
Foundation (Hector Stiftung) have recently established the Hector Institute for Translational Brain Research (HITBR).
This institute exploits human induced pluripotent stem cell (iPSC) technology with the goal to identify new targets through the study
of neural cells and tissues (organoids) in brain disorders with focus on psychiatric diseases and brain malignancies.
We are currently seeking an outstanding researcher as head of an independent junior research group (equivalent to an appointment
at the assistant professor level). The successful candidate should have international research experience and excellent scientific
track record in iPSC technology and its application.
The candidate should provide an innovative research program focusing on fundamental and/or translational aspects of brain malignancies
such as cancer initiation, growth control of neural tissue, the cellular origin of brain cancer or therapeutic intervention using human
iPSC-based models. Inclusion of state-of-the-art techniques such as brain organoids or CRISPR/Cas9-based genome editing is encouraged.
The group will be hosted at the German Cancer Research Center (DKFZ) in Heidelberg and tightly interact with the HITBR groups
located at the CIMH in Mannheim. The DKFZ is a member of the Helmholtz Association of German research centers and with
approximately 2,900 employees the largest biomedical research institute in Germany as well as one of Europe’s leading
cancer research centers. Our mission is to unravel the causes and mechanisms underlying cancer development and progression
and, based on innovative research, develop novel strategies for the diagnosis, early detection, prevention and treatment
To efficiently translate novel findings from basic science into the clinic, the National Center for Tumor Diseases (NCT) was
established by the DKFZ, Heidelberg University Hospital and German Cancer Aid. Located on the biomedical campus in Heidelberg,
the DKFZ is embedded in a highly attractive scientific environment offering a broad spectrum of opportunities for collaborations.
Moreover, we provide excellent research conditions, an international and collegial research environment and access to
state-of-the-art core facilities.
Eligible applicants are scientists (PhD, MD or MD-PhD degree) with more than 2 and less than 6 years of postdoctoral
experience at the time of application (which can be extended for family-related matters / nursing of family members
or residency training periods).
The ideal candidate is expected to pursue highly innovative research projects at the frontiers of human induced pluripotent
stem cells and brain cancer and should be able to successfully raise extramural funding.
To apply, please submit a cover letter, curriculum vitae, list of publications, summary of past research and future plans (max.
5 pages) and names and addresses of two to three references using our online application portal
Applications will be preselected and short listed candidates will be invited to the DKFZ to present and discuss their research and future plans.
For further informationabout the position or application procedure please contact
Dr. Claudia Reschke, phone +49 6221 42-1670.
Um unsere Webseite optimal gestalten und fortlaufend verbessern zu können, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Weitere Informationen sowie Hinweise dazu, wie Sie die Speicherung der Cookies verhindern können, finden Sie in unserer Datenschutzerklärung.